Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ogwang MD"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-13 z 13
    Tytuł:
    Human leukocyte antigen-DQA1*04:01 and rs2040406 variants are associated with elevated risk of childhood Burkitt lymphoma.
    Autorzy:
    Liu Z; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
    Luo Y; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; Center for Data Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Division of Rheumatology, Immunology, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
    Kirimunda S; College of Health Sciences, Makerere University, Kampala, Uganda.
    Verboom M; Institute of Transfusion Medicine and Transplant Engineering, Hanover, Germany.
    Onabajo OO; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
    Gouveia MH; Center for Research on Genomics & Global Health, NHGRI, National Institutes of Health, Bethesda, MD, USA.
    Ogwang MD; St. Mary's Hospital, Lacor, Gulu, Uganda.; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
    Kerchan P; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; Kuluva Hospital, Arua, Uganda.
    Reynolds SJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
    Tenge CN; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; Moi University College of Health Sciences, Eldoret, Kenya.
    Were PA; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
    Kuremu RT; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; Moi University College of Health Sciences, Eldoret, Kenya.
    Wekesa WN; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; Moi University College of Health Sciences, Eldoret, Kenya.
    Masalu N; Bugando Medical Center, Mwanza, Tanzania.
    Kawira E; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; Shirati Health, Education, and Development Foundation, Shirati, Tanzania.
    Kinyera T; St. Mary's Hospital, Lacor, Gulu, Uganda.; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
    Otim I; St. Mary's Hospital, Lacor, Gulu, Uganda.; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
    Legason ID; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; Kuluva Hospital, Arua, Uganda.
    Nabalende H; St. Mary's Hospital, Lacor, Gulu, Uganda.; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
    Dhudha H; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; Shirati Health, Education, and Development Foundation, Shirati, Tanzania.
    Ayers LW; Department of Pathology, The Ohio State University, Columbus, OH, USA.
    Bhatia K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
    Goedert JJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
    Cole N; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Luo W; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Liu J; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Manning M; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Hicks B; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Prokunina-Olsson L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
    Chagaluka G; Departments of Pediatrics and Surgery, Kamuzu University of Health Sciences (formerly College of Medicine), University of Malawi, Blantyre, Malawi.
    Johnston WT; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.
    Mutalima N; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.; Cancer Epidemiology Unit, University of Oxford, Oxford, UK.
    Borgstein E; Departments of Pediatrics and Surgery, Kamuzu University of Health Sciences (formerly College of Medicine), University of Malawi, Blantyre, Malawi.
    Liomba GN; Departments of Pediatrics and Surgery, Kamuzu University of Health Sciences (formerly College of Medicine), University of Malawi, Blantyre, Malawi.
    Kamiza S; Departments of Pediatrics and Surgery, Kamuzu University of Health Sciences (formerly College of Medicine), University of Malawi, Blantyre, Malawi.
    Mkandawire N; Departments of Pediatrics and Surgery, Kamuzu University of Health Sciences (formerly College of Medicine), University of Malawi, Blantyre, Malawi.
    Mitambo C; National Health Sciences Research Committee, Research Department, Ministry of Health, Lilongwe, Malawi.
    Molyneux EM; Departments of Pediatrics and Surgery, Kamuzu University of Health Sciences (formerly College of Medicine), University of Malawi, Blantyre, Malawi.
    Newton R; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.
    Hsing AW; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
    Mensah JE; University of Ghana Medical School, Accra, Ghana.
    Adjei AA; University of Ghana Medical School, Accra, Ghana.
    Hutchinson A; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Carrington M; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
    Yeager M; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Blasczyk R; Institute of Transfusion Medicine and Transplant Engineering, Hanover, Germany.
    Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
    Raychaudhuri S; Center for Data Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Division of Rheumatology, Immunology, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
    Mbulaiteye SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. .
    Pokaż więcej
    Źródło:
    Communications biology [Commun Biol] 2024 Jan 05; Vol. 7 (1), pp. 41. Date of Electronic Publication: 2024 Jan 05.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Burkitt Lymphoma*/genetics
    Epstein-Barr Virus Infections*/complications
    Epstein-Barr Virus Infections*/genetics
    Child ; Humans ; Herpesvirus 4, Human/genetics ; HLA-DQ alpha-Chains/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A protocol to clinically evaluate liquid biopsies as a tool to speed up diagnosis of children and young adults with aggressive infection-related lymphoma in East Africa "(AI-REAL)".
    Autorzy:
    Legason ID; AI-REAL Study, St Mary's Hospital Lacor, Gulu& African Field Epidemiology Network, 180, Gulu-Uganda. African Field Epidemiology Network, 12874, Kampala, Uganda. .
    Ogwang MD; AI-REAL Study, St Mary's Hospital Lacor, Gulu& African Field Epidemiology Network, 180, Gulu-Uganda. African Field Epidemiology Network, 12874, Kampala, Uganda.
    Chamba C; AI-REAL Study, Muhimbili University of Health and Allied Sciences, Dar es Salam, Tanzania.
    Mkwizu E; AI-REAL Study, Kilimanjaro Christian Medical Center, Moshi, Tanzania.; Kilimanjaro Christian Medical University College, Moshi, Tanzania.
    El Mouden C; AI-REAL Study, Muhimbili National Hospital, Dar es Salaam, Tanzania.
    Mwinula H; Molecular Diagnostic Center, Department of Oncology, University of Oxford, Oxford, UK.
    Chirande L; AI-REAL Study, Muhimbili University of Health and Allied Sciences, Dar es Salam, Tanzania.
    Schuh A; AI-REAL Study, Muhimbili National Hospital, Dar es Salaam, Tanzania.
    Chiwanga F; AI-REAL Study, Muhimbili National Hospital, Dar es Salaam, Tanzania.
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2022 May 02; Vol. 22 (1), pp. 484. Date of Electronic Publication: 2022 May 02.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Circulating Tumor DNA*
    Lymphoma, Non-Hodgkin*
    Neoplasms*/diagnosis
    Africa, Eastern ; Biomarkers, Tumor/genetics ; Child ; Herpesvirus 4, Human/genetics ; Humans ; Liquid Biopsy/methods ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Incidental cholecystocolonic fistula in obstructive jaundice.
    Autorzy:
    Okidi R; Department of Surgery Lacor Hospital Gulu Uganda.; Faculty of Medicine Gulu University Gulu Uganda.
    Ogwang MD; Department of Surgery Lacor Hospital Gulu Uganda.; Faculty of Medicine Gulu University Gulu Uganda.
    Natumanya R; Department of Surgery Lacor Hospital Gulu Uganda.
    Mukalazi A; Department of Surgery Lacor Hospital Gulu Uganda.
    Kyomuhendo T; Mildmay Uganda Hospital Kampala Uganda.
    Okello TR; Department of Surgery Lira University Lira Uganda.
    Pokaż więcej
    Źródło:
    Clinical case reports [Clin Case Rep] 2021 Jul 16; Vol. 9 (7), pp. e04510. Date of Electronic Publication: 2021 Jul 16 (Print Publication: 2021).
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Inverse association of falciparum positivity with endemic Burkitt lymphoma is robust in analyses adjusting for pre-enrollment malaria in the EMBLEM case-control study.
    Autorzy:
    Peprah S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Infections and Immunoepidemiology Branch, 9609 Medical Center Dr, Rm. 6E-118, MSC 3330, Bethesda, MD, 20892, USA.
    Ogwang MD; EMBLEM Study, St. Mary's Hospital, Lacor, Gulu & African Field Epidemiology Network, Kampala, Uganda.
    Kerchan P; EMBLEM Study, Kuluva Hospital, Arua & African Field Epidemiology Network, Kampala, Uganda.
    Reynolds SJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
    Tenge CN; EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.; Moi Teaching and Referral Hospital (MTRH), Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
    Were PA; EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.; Moi Teaching and Referral Hospital (MTRH), Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
    Kuremu RT; EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.; Moi Teaching and Referral Hospital (MTRH), Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
    Wekesa WN; EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.; Moi Teaching and Referral Hospital (MTRH), Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
    Masalu N; EMBLEM Study, Bugando Medical Center, Mwanza, Tanzania.
    Kawira E; EMBLEM Study, Shirati Health and Educational Foundation, Shirati, Tanzania.
    Otim I; EMBLEM Study, St. Mary's Hospital, Lacor, Gulu & African Field Epidemiology Network, Kampala, Uganda.
    Legason ID; EMBLEM Study, Kuluva Hospital, Arua & African Field Epidemiology Network, Kampala, Uganda.
    Ayers LW; Department of Pathology, The Ohio State University, Columbus, OH, USA.
    Bhatia K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Infections and Immunoepidemiology Branch, 9609 Medical Center Dr, Rm. 6E-118, MSC 3330, Bethesda, MD, 20892, USA.
    Goedert JJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Infections and Immunoepidemiology Branch, 9609 Medical Center Dr, Rm. 6E-118, MSC 3330, Bethesda, MD, 20892, USA.
    Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Infections and Immunoepidemiology Branch, 9609 Medical Center Dr, Rm. 6E-118, MSC 3330, Bethesda, MD, 20892, USA.
    Mbulaiteye SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Infections and Immunoepidemiology Branch, 9609 Medical Center Dr, Rm. 6E-118, MSC 3330, Bethesda, MD, 20892, USA. .
    Pokaż więcej
    Źródło:
    Infectious agents and cancer [Infect Agent Cancer] 2021 Jun 07; Vol. 16 (1), pp. 40. Date of Electronic Publication: 2021 Jun 07.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Endemic Burkitt lymphoma: a complication of asymptomatic malaria in sub-Saharan Africa based on published literature and primary data from Uganda, Tanzania, and Kenya.
    Autorzy:
    Redmond LS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
    Ogwang MD; EMBLEM Study, St. Mary's Hospital Lacor, Gulu, Uganda.; African Field Epidemiology Network, Kampala, Uganda.
    Kerchan P; African Field Epidemiology Network, Kampala, Uganda.; EMBLEM Study, Kuluva Hospital Kuluva, Arua, Uganda.
    Reynolds SJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
    Tenge CN; EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.
    Were PA; EMBLEM Study, Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
    Kuremu RT; EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.
    Masalu N; EMBLEM Study, Bugando Medical Center, Mwanza, Tanzania.
    Kawira E; EMBLEM Study, Shirati Health and Educational Foundation, Shirati, Tanzania.
    Otim I; EMBLEM Study, St. Mary's Hospital Lacor, Gulu, Uganda.; African Field Epidemiology Network, Kampala, Uganda.
    Legason ID; African Field Epidemiology Network, Kampala, Uganda.; EMBLEM Study, Kuluva Hospital Kuluva, Arua, Uganda.
    Dhudha H; EMBLEM Study, Shirati Health and Educational Foundation, Shirati, Tanzania.
    Ayers LW; Department of Pathology, The Ohio State University, Columbus, OH, USA.
    Bhatia K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
    Goedert JJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
    Mbulaiteye SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. .
    Pokaż więcej
    Źródło:
    Malaria journal [Malar J] 2020 Jul 28; Vol. 19 (1), pp. 239. Date of Electronic Publication: 2020 Jul 28.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Burkitt Lymphoma/*epidemiology
    Malaria, Falciparum/*epidemiology
    Adolescent ; Asymptomatic Infections/epidemiology ; Burkitt Lymphoma/parasitology ; Case-Control Studies ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Kenya/epidemiology ; Malaria, Falciparum/complications ; Malaria, Falciparum/parasitology ; Male ; Plasmodium falciparum/physiology ; Prevalence ; Tanzania/epidemiology ; Uganda/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Genetic signatures of gene flow and malaria-driven natural selection in sub-Saharan populations of the "endemic Burkitt Lymphoma belt".
    Autorzy:
    Gouveia MH; Instituto de Pesquisa René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.; Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Center for Research on Genomics & Global Health, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Bergen AW; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Borda V; Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
    Nunes K; Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
    Leal TP; Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Department of Statistics, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
    Ogwang MD; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
    Yeboah ED; University of Ghana Medical School, Accra, Ghana.
    Mensah JE; University of Ghana Medical School, Accra, Ghana.
    Kinyera T; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
    Otim I; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
    Nabalende H; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
    Legason ID; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
    Mpoloka SW; Department of Biological Sciences, University of Botswana, Gaborone, Botswana.
    Mokone GG; Department of Biomedical Sciences, University of Botswana School of Medicine, Gaborone, Botswana.
    Kerchan P; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
    Bhatia K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Reynolds SJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Birtwum RB; University of Ghana Medical School, Accra, Ghana.
    Adjei AA; University of Ghana Medical School, Accra, Ghana.
    Tettey Y; University of Ghana Medical School, Accra, Ghana.
    Tay E; University of Ghana Medical School, Accra, Ghana.
    Hoover R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Biggar RJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Goedert JJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Prokunina-Olsson L; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Dean M; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Yeager M; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, US Department of Health and Human Services, Frederick, Maryland, United States of America.
    Lima-Costa MF; Instituto de Pesquisa René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.
    Hsing AW; Stanford Cancer Institute, Stanford University, Stanford, California, United States of America.
    Tishkoff SA; Department of Genetics and Biology, University of Pennsylvania, Philadelphia, United States of America.
    Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Tarazona-Santos E; Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
    Mbulaiteye SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America.
    Pokaż więcej
    Źródło:
    PLoS genetics [PLoS Genet] 2019 Mar 08; Vol. 15 (3), pp. e1008027. Date of Electronic Publication: 2019 Mar 08 (Print Publication: 2019).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Gene Flow*
    Selection, Genetic*
    Burkitt Lymphoma/*genetics
    Malaria, Falciparum/*genetics
    Adolescent ; Africa South of the Sahara ; Aged ; Burkitt Lymphoma/epidemiology ; Case-Control Studies ; Child ; Child, Preschool ; Endemic Diseases ; Female ; Genetics, Population ; Genome-Wide Association Study ; Ghana/epidemiology ; Human Migration ; Humans ; Incidence ; Infant ; Infant, Newborn ; Malaria, Falciparum/epidemiology ; Male ; Middle Aged ; Models, Genetic ; Plasma Membrane Calcium-Transporting ATPases/genetics ; Polymorphism, Single Nucleotide ; Uganda/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A cross-sectional study of asymptomatic Plasmodium falciparum infection burden and risk factors in general population children in 12 villages in northern Uganda.
    Autorzy:
    Maziarz M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Dr, Rm. 6E118 MSC 9706, Bethesda, MD, 20892-9704, USA.
    Nabalende H; EMBLEM Study, African Field Epidemiology Network, Kampala & St. Mary's Hospital, Lacor, Gulu, Uganda.
    Otim I; EMBLEM Study, African Field Epidemiology Network, Kampala & St. Mary's Hospital, Lacor, Gulu, Uganda.
    Legason ID; EMBLEM Study, African Field Epidemiology Network, Kampala & St. Mary's Hospital, Lacor, Gulu, Uganda.
    Kinyera T; EMBLEM Study, African Field Epidemiology Network, Kampala & St. Mary's Hospital, Lacor, Gulu, Uganda.
    Ogwang MD; EMBLEM Study, African Field Epidemiology Network, Kampala & St. Mary's Hospital, Lacor, Gulu, Uganda.
    Talisuna AO; World Health Organization, Regional Office for Africa, Brazzaville, Congo.
    Reynolds SJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
    Kerchan P; EMBLEM Study, African Field Epidemiology Network, Kampala & St. Mary's Hospital, Lacor, Gulu, Uganda.
    Bhatia K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Dr, Rm. 6E118 MSC 9706, Bethesda, MD, 20892-9704, USA.
    Biggar RJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Dr, Rm. 6E118 MSC 9706, Bethesda, MD, 20892-9704, USA.
    Goedert JJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Dr, Rm. 6E118 MSC 9706, Bethesda, MD, 20892-9704, USA.
    Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Dr, Rm. 6E118 MSC 9706, Bethesda, MD, 20892-9704, USA.
    Mbulaiteye SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Dr, Rm. 6E118 MSC 9706, Bethesda, MD, 20892-9704, USA. .
    Pokaż więcej
    Źródło:
    Malaria journal [Malar J] 2018 Jun 20; Vol. 17 (1), pp. 240. Date of Electronic Publication: 2018 Jun 20.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Asymptomatic Infections/*epidemiology
    Malaria, Falciparum/*epidemiology
    Plasmodium falciparum/*isolation & purification
    Adolescent ; Child ; Child, Preschool ; Cross-Sectional Studies ; Diagnostic Tests, Routine ; Family Characteristics ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Microscopy ; Prevalence ; Risk Factors ; Rural Population ; Uganda/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Frequency of EBV LMP-1 Promoter and Coding Variations in Burkitt Lymphoma Samples in Africa and South America and Peripheral Blood in Uganda.
    Autorzy:
    Liao HM; Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA. .
    Liu H; Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA. .
    Lei H; Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA. .
    Li B; Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA. .
    Chin PJ; Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA. .
    Tsai S; Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA. .
    Bhatia K; Cancer Genetics, Inc., Rutherford, NJ 07070, USA. .
    Gutierrez M; Laboratorio Stamboulian, Laboratorio Stamboulian, Buenos Aires 1414, Argentina. .
    Epelman S; Department of Pediatric Oncology, St Marcelina Hospital, Sao Paolo 08270-070, Brazil. .
    Biggar RJ; Infections and Immunoepidemiology Branch, National Cancer Institute, Bethesda, MD 20892, USA. .
    Nkrumah F; Noguchi Memorial Institute, Kor Le Bu University, P.O. Box LG 581 Legon, Accra, Ghana. .
    Neequaye J; Department of Child Health, University of Ghana, P.O. Box LG 25 Legon, Accra, Ghana. .
    Ogwang MD; EMBLEM Study, St. Mary's Hospital, Lacor, P.O. Box 180, Gulu, Uganda. ogwang..
    Reynolds SJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA. .
    Lo SC; Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA. .
    Mbulaiteye SM; Infections and Immunoepidemiology Branch, National Cancer Institute, Bethesda, MD 20892, USA. .
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2018 Jun 02; Vol. 10 (6). Date of Electronic Publication: 2018 Jun 02.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Age and geographic patterns of Plasmodium falciparum malaria infection in a representative sample of children living in Burkitt lymphoma-endemic areas of northern Uganda.
    Autorzy:
    Maziarz M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
    Kinyera T; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; St. Mary's Hospital, Lacor, Gulu, Uganda.
    Otim I; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; St. Mary's Hospital, Lacor, Gulu, Uganda.
    Kagwa P; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; St. Mary's Hospital, Lacor, Gulu, Uganda.
    Nabalende H; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; St. Mary's Hospital, Lacor, Gulu, Uganda.
    Legason ID; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; St. Mary's Hospital, Lacor, Gulu, Uganda.
    Ogwang MD; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; St. Mary's Hospital, Lacor, Gulu, Uganda.
    Kirimunda S; Department of Medical Microbiology, Makerere Medical School, Kampala, Uganda.
    Emmanuel B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; University of Maryland, Baltimore, MD, USA.
    Reynolds SJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
    Kerchan P; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.; Kuluva Hospital, Kuluva, Arua, Uganda.
    Joloba MM; Department of Medical Microbiology, Makerere Medical School, Kampala, Uganda.
    Bergen AW; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
    Bhatia K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
    Talisuna AO; World Health Organization, Regional Office for Africa, Brazzaville, Congo.
    Biggar RJ; Institute of Health and Biotechnical Innovation, Queensland University of Technology, Brisbane, Australia.
    Goedert JJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
    Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. .
    Mbulaiteye SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. .
    Pokaż więcej
    Źródło:
    Malaria journal [Malar J] 2017 Mar 20; Vol. 16 (1), pp. 124. Date of Electronic Publication: 2017 Mar 20.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Intramural
    MeSH Terms:
    Endemic Diseases*
    Burkitt Lymphoma/*epidemiology
    Malaria, Falciparum/*epidemiology
    Adolescent ; Child ; Child, Preschool ; Diagnostic Tests, Routine ; Female ; Humans ; Infant ; Infant, Newborn ; Malaria, Falciparum/parasitology ; Male ; Plasmodium falciparum/isolation & purification ; Prevalence ; Sensitivity and Specificity ; Uganda/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    "The Cango Lyec Project - Healing the Elephant": HIV related vulnerabilities of post-conflict affected populations aged 13-49 years living in three Mid-Northern Uganda districts.
    Autorzy:
    Malamba SS; Uganda Virus Research Institute (UVRI) - HIV Reference Laboratory Program, Entebbe, Uganda. .; Northern Uganda Program on Health Sciences, c/o Uganda Virus Research Institute, HIV Reference Laboratory, P.O. Box 49, Entebbe, Kampala, Uganda. .
    Muyinda H; Makerere University, Child Health Development Center, Kampala, Uganda.
    Spittal PM; University of British Columbia, School of Population & Public Health, Vancouver, Canada.
    Ekwaru JP; School of Public Health, University of Alberta, Alberta, Canada.
    Kiwanuka N; Uganda Virus Research Institute - International HIV/AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Entebbe, Uganda.; Makerere University College of Health Sciences, Kampala, Uganda.
    Ogwang MD; St. Mary's Hospital-Lacor, Gulu, Uganda.; Northern Uganda Program on Health Sciences, Kampala, Uganda.
    Odong P; Northern Uganda Program on Health Sciences, Kampala, Uganda.
    Kitandwe PK; Uganda Virus Research Institute - International HIV/AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Entebbe, Uganda.
    Katamba A; Makerere University College of Health Sciences, Kampala, Uganda.
    Jongbloed K; University of British Columbia, School of Population & Public Health, Vancouver, Canada.
    Sewankambo NK; Makerere University College of Health Sciences, Kampala, Uganda.
    Kinyanda E; MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.; Butabika National Psychiatric Referral Hospital, Nakawa, Uganda.
    Blair A; University of British Columbia, School of Population & Public Health, Vancouver, Canada.
    Schechter MT; University of British Columbia, School of Population & Public Health, Vancouver, Canada.
    Pokaż więcej
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2016 Nov 21; Vol. 16 (1), pp. 690. Date of Electronic Publication: 2016 Nov 21.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Warfare*
    Combat Disorders/*epidemiology
    HIV Infections/*epidemiology
    Adolescent ; Adult ; Combat Disorders/psychology ; Depression/epidemiology ; Evidence-Based Practice ; Female ; HIV Infections/prevention & control ; HIV Infections/psychology ; Health Services Needs and Demand ; Health Surveys ; Humans ; Male ; Middle Aged ; Prevalence ; Uganda/epidemiology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
    Autorzy:
    Schmitz R; Metabolism Branch Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.
    Young RM
    Ceribelli M
    Jhavar S
    Xiao W
    Zhang M
    Wright G
    Shaffer AL
    Hodson DJ
    Buras E
    Liu X
    Powell J
    Yang Y
    Xu W
    Zhao H
    Kohlhammer H
    Rosenwald A
    Kluin P
    Müller-Hermelink HK
    Ott G
    Gascoyne RD
    Connors JM
    Rimsza LM
    Campo E
    Jaffe ES
    Delabie J
    Smeland EB
    Ogwang MD
    Reynolds SJ
    Fisher RI
    Braziel RM
    Tubbs RR
    Cook JR
    Weisenburger DD
    Chan WC
    Pittaluga S
    Wilson W
    Waldmann TA
    Rowe M
    Mbulaiteye SM
    Rickinson AB
    Staudt LM
    Pokaż więcej
    Źródło:
    Nature [Nature] 2012 Oct 04; Vol. 490 (7418), pp. 116-20. Date of Electronic Publication: 2012 Aug 12.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genomics*
    Molecular Targeted Therapy*
    Burkitt Lymphoma/*drug therapy
    Burkitt Lymphoma/*genetics
    Basic Helix-Loop-Helix Transcription Factors/antagonists & inhibitors ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Basic Helix-Loop-Helix Transcription Factors/metabolism ; Burkitt Lymphoma/metabolism ; Burkitt Lymphoma/pathology ; Cell Cycle ; Cyclin D3/genetics ; Cyclin D3/metabolism ; Cyclin-Dependent Kinase 6/metabolism ; Genes, myc/genetics ; High-Throughput Nucleotide Sequencing ; Humans ; Inhibitor of Differentiation Proteins/genetics ; Inhibitor of Differentiation Proteins/metabolism ; Neoplasm Proteins/genetics ; Neoplasm Proteins/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; RNA Interference ; Receptors, Antigen, B-Cell/metabolism ; Signal Transduction
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls?
    Autorzy:
    Baik S; Infections and Immunoepidemiology Branch, National Cancer Institute, Bethesda, MD, USA. .
    Mbaziira M
    Williams M
    Ogwang MD
    Kinyera T
    Emmanuel B
    Ziegler JL
    Reynolds SJ
    Mbulaiteye SM
    Pokaż więcej
    Źródło:
    Infectious agents and cancer [Infect Agent Cancer] 2012 Mar 13; Vol. 7 (1), pp. 5. Date of Electronic Publication: 2012 Mar 13.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology.
    Autorzy:
    Ogwang MD; Department of Surgery, St Mary's Hospital, Lacor, Gulu, Uganda.
    Zhao W
    Ayers LW
    Mbulaiteye SM
    Pokaż więcej
    Źródło:
    Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2011 Apr; Vol. 135 (4), pp. 445-50.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Health Services Accessibility*
    Burkitt Lymphoma/*diagnosis
    Burkitt Lymphoma/epidemiology ; Child ; Developing Countries/statistics & numerical data ; Female ; Humans ; Male ; Public Health ; Referral and Consultation ; Reproducibility of Results ; Uganda/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-13 z 13

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies